High throughput peptide mapping method for analysis of site specific monoclonal antibody oxidation.

Oxidation of therapeutic monoclonal antibodies (mAbs) often occurs on surface exposed methionine and tryptophan residues during their production in cell culture, purification, and storage, and can potentially impact the binding to their targets. Characterization of site specific oxidation is critical for antibody quality control. Antibody oxidation is commonly determined by peptide mapping/LC-MS methods, which normally require a long (up to 24h) digestion step. The prolonged sample preparation procedure could result in oxidation artifacts of susceptible methionine and tryptophan residues. In this paper, we developed a rapid and simple UV based peptide mapping method that incorporates an 8-min trypsin in-solution digestion protocol for analysis of oxidation. This method is able to determine oxidation levels at specific residues of a mAb based on the peptide UV traces within <1h, from either TBHP treated or UV light stressed samples. This is the simplest and fastest method reported thus far for site specific oxidation analysis, and can be applied for routine or high throughput analysis of mAb oxidation during various stability and degradation studies. By using the UV trace, the method allows more accurate measurement than mass spectrometry and can be potentially implemented as a release assay. It has been successfully used to monitor antibody oxidation in real time stability studies.

[1]  Ying Zhang,et al.  Analysis and purification of IgG4 bispecific antibodies by a mixed-mode chromatography. , 2015, Analytical biochemistry.

[2]  L. Zitvogel,et al.  Cancer: Antibodies regulate antitumour immunity , 2015, Nature.

[3]  Ziping Wei,et al.  Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus. , 2007, Analytical chemistry.

[4]  Hongcheng Liu,et al.  Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  Mohammed Shameem,et al.  Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications , 2014, mAbs.

[6]  David P. Hamilton,et al.  Structural Characterization of New Microcystins Containing Tryptophan and Oxidized Tryptophan Residues , 2013, Marine drugs.

[7]  Hongcheng Liu,et al.  A conventional procedure to reduce Asn deamidation artifacts during trypsin peptide mapping. , 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  Johann Holzmann,et al.  Site-specific characterization and absolute quantification of pegfilgrastim oxidation by top-down high-performance liquid chromatography-mass spectrometry. , 2015, Analytical chemistry.

[9]  Hanns-Christian Mahler,et al.  Analytical protein a chromatography as a quantitative tool for the screening of methionine oxidation in monoclonal antibodies. , 2012, Journal of pharmaceutical sciences.

[10]  Mohammed Shameem,et al.  Analysis of monoclonal antibody oxidation by simple mixed mode chromatography. , 2016, Journal of chromatography. A.

[11]  R. Campbell,et al.  Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor. , 2009, International journal of peptide and protein research.

[12]  B. Warrack,et al.  Characterization of protein therapeutics by mass spectrometry: recent developments and future directions. , 2011, Drug discovery today.

[13]  Thomayant Prueksaritanont,et al.  Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors. , 2009, Molecular immunology.

[14]  Alain Van Dorsselaer,et al.  Characterization of therapeutic antibodies and related products. , 2013, Analytical chemistry.

[15]  Gang Huang,et al.  Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn , 2009, Protein science : a publication of the Protein Society.

[16]  Catherine D. Kim,et al.  Determination of the origin of the N‐terminal pyro‐glutamate variation in monoclonal antibodies using model peptides , 2007, Biotechnology and bioengineering.

[17]  W. Ens,et al.  Deamidation of -Asn-Gly- sequences during sample preparation for proteomics: Consequences for MALDI and HPLC-MALDI analysis. , 2006, Analytical chemistry.

[18]  Hongcheng Liu,et al.  Accurate determination of protein methionine oxidation by stable isotope labeling and LC-MS analysis. , 2013, Analytical chemistry.

[19]  Xue Han,et al.  Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. , 2015, The Journal of clinical investigation.

[20]  Brian M. Murphy,et al.  Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.

[21]  Ying Zhang,et al.  A new tool for monoclonal antibody analysis , 2014, mAbs.

[22]  Li Zang,et al.  Residual metals cause variability in methionine oxidation measurements in protein pharmaceuticals using LC-UV/MS peptide mapping. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  A. Ambrogelly,et al.  Ultrafast and high-throughput N-glycan analysis for monoclonal antibodies , 2016, mAbs.

[24]  Huub Schellekens,et al.  Structure-Immunogenicity Relationships of Therapeutic Proteins , 2004, Pharmaceutical Research.

[25]  I. Mellman,et al.  Oncology meets immunology: the cancer-immunity cycle. , 2013, Immunity.

[26]  Y. Lyubarskaya,et al.  Determination of protein oxidation by mass spectrometry and method transfer to quality control. , 2006, Journal of chromatography. A.

[27]  W. Xu,et al.  Development of a sample preparation method for monitoring correct disulfide linkages of monoclonal antibodies by liquid chromatography-mass spectrometry. , 2016, Analytical biochemistry.

[28]  Igor A Kaltashov,et al.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. , 2012, Biotechnology advances.

[29]  D. Chelius,et al.  Identification and characterization of oxidation and deamidation sites in monoclonal rat/mouse hybrid antibodies. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  Da Ren,et al.  Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation. , 2008, Biochemistry.

[31]  Guodong Chen,et al.  Structural mass spectrometry in biologics discovery: advances and future trends. , 2012, Drug discovery today.

[32]  Yang Wang,et al.  Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies. , 2011, Molecular immunology.

[33]  Nigel Jenkins,et al.  Post-translational Modifications of Recombinant Proteins: Significance for Biopharmaceuticals , 2008, Molecular biotechnology.

[34]  H. Yamaguchi,et al.  Enzyme‐immobilized reactors for rapid and efficient sample preparation in MS‐based proteomic studies , 2013, Proteomics.

[35]  Hongcheng Liu,et al.  Heterogeneity of monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[36]  L. Weiner,et al.  Mechanisms of action of therapeutic antibodies for cancer. , 2015, Molecular immunology.

[37]  Hongcheng Liu,et al.  Structural effect of deglycosylation and methionine oxidation on a recombinant monoclonal antibody. , 2008, Molecular immunology.

[38]  S. Burman,et al.  Facile method of quantification for oxidized tryptophan degradants of monoclonal antibody by mixed mode ultra performance liquid chromatography. , 2012, Journal of chromatography. A.

[39]  R. Bass,et al.  N-terminal Glutamate to Pyroglutamate Conversion in Vivo for Human IgG2 Antibodies , 2011, The Journal of Biological Chemistry.